GSK-3903133A

N/A

Report date: 2026/05/12 09:09:12

Base Information

Drug NameGSK-3903133A

Drug Alias NameRG-SAM [CNE] vaccineRabies SAM (CNE) vaccinerabies glycoprotein G (RG) vaccineGSK-3903133A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsVirus Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsVirus Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A